Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 1989Journal of Clinical Oncology

Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphomas who are still responsive to conventional-dose therapy.

View Full Paper
Ask AI
Bookmark
Share

Authors

John G. Gribben
John G. GribbenBoston UniversityAGAnthony H. GoldstoneNorthwestern UniversityDLDavid C. LinchCRUK Lung Cancer Centre of Excellence

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gribben et al. (1989) studied this question.

synapsesocial.com/papers/6a0feba5d13714ec96fed1c0https://doi.org/10.1200/jco.1989.7.11.1621
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1MACOP-B Chemotherapy for the Treatment of Diffuse Large-Cell Lymphoma1985 · 669 citations
  2. 2Phase III study of BCOP v CHOP in unfavorable categories of malignant lymphoma: a Southeastern Cancer Study Group trial.1985 · 43 citations
  3. 3Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: significance and management.1988 · 180 citations
  4. 4DQIS — Distributed Quorum-Based Independent Immune Surveillance: A Theoretical Framework for Byzantine Fault Tolerance for Multi-Channel Immune Surveillance2026 · 1,340 citations